Fifth Third Bancorp
ANIK icon

Fifth Third Bancorp’s Anika Therapeutics ANIK Stock Holding History

Fifth Third Bancorp’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01K Buy
+70
New +$813 ﹤0.01% 4128
2023
Q4 		– Sell
-214
Closed -$3.99K – 2496
2023
Q3 		$3.99K Buy
+214
New +$4.44K ﹤0.01% 2232
2023
Q2 		– Sell
-13
Closed -$373 – 2615
2023
Q1 		$373 Buy
+13
New +$387 ﹤0.01% 2720
2022
Q2 		– Sell
-55
Closed -$1K – 2638
2022
Q1 		$1K Sell
55
-65
-54% -$1.98K ﹤0.01% 2582
2021
Q4 		$4K Buy
120
+65
+118% +$2.6K ﹤0.01% 2374
2021
Q3 		$2K Sell
55
-189
-77% -$7.79K ﹤0.01% 2415
2021
Q2 		$11K Buy
244
+55
+29% +$2.34K ﹤0.01% 1968
2021
Q1 		$8K Buy
+189
New +$7.17K ﹤0.01% 2057
2018
Q3 		– Sell
-156
Closed -$5K – 2185
2018
Q2 		$5K Sell
156
-155
-50% -$6.38K ﹤0.01% 2031
2018
Q1 		$15K Buy
+311
New +$17.6K ﹤0.01% 1752
2016
Q1 		– Sell
-41
Closed -$2K – 2317
2015
Q4 		$2K Buy
41
+1
+3% +$38 ﹤0.01% 2446
2015
Q3 		$1K Buy
40
+14
+54% +$488 ﹤0.01% 2714
2015
Q2 		$1K Hold
26
– – ﹤0.01% 2676
2015
Q1 		$1K Buy
+26
New +$1.05K ﹤0.01% 2582

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fifth Third Bancorp's ANIK Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Anika Therapeutics (ANIK) in Q1 2026: 70 shares worth $1.01K. The stake represents ﹤0.01% of the portfolio and ranks #4128 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in ANIK as recently as Q3 2023.

Fifth Third Bancorp first reported a position in ANIK in Q1 2015 and has held it in 14 quarters since. The position peaked at $15K in Q1 2018. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Fifth Third Bancorp held 70 shares of Anika Therapeutics worth $1.01K as of Q1 2026.
  • Anika Therapeutics was a new Fifth Third Bancorp position in Q1 2026.
  • Anika Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #4128 holding.
  • Fifth Third Bancorp first reported a position in Anika Therapeutics in Q1 2015 and has held it in 14 quarters since.
  • Fifth Third Bancorp's Anika Therapeutics position peaked at $15K in Q1 2018.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.